The 2020/2021 strategic funding challenge for European innovative SMEs - Oct. 2020

Insight in the current financing climate of the Life Sciences, MedTech and Health.

A 10 minute read article

We share 3 important questions that any innovative SME should be able to answer before reaching out to investors.

Find the full article: Here

Nov 2020 - Apply now for Eurostars funding: €1.000.000+ funding for innovative R&D projects with 2 or more innovative SMEs from 2 Eureka countries!

Update: COVID-19 R&D Funding May 7th 2020

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 5/07/2020

Over 20 Dutch and EU-wide calls are open to apply for funding to cover your COVID-19 related R&D projects!

In May, many new funding opportunities and partnering events are launched (and closing!) – be aware that fast action is needed!

  • ZonMW and NWO (Dutch research funding) opened 3 calls with deadlines on May 14th and May 25th
  • New funding opportunities are now open from CEPI.
  • The new COVID-19 funding round by HORIZON is still expected to be launched by mid-May.

The full overview of current funding opportunities and relevant (partnering)links are provided here.

Update: COVID-19 R&D Funding May 1st 2020

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 5/01/2020

Over 15 Dutch and EU-wide funding bodies are now  lined-up to fund research and development projects to solve all challenges related to the COVID-19 outbreak.

In May many new funding opportunities and partnering events are launched (and closing!) – be aware that fast action is needed!

  • ZonMW and NWO (Dutch research funding) announced Today the first deadlines for funding: May 14th
  • You can still sign up for the Health~Holland COVID-19 virtual partnering event on May 4th.
  • New funding opportunities are now open from PRACE, EGI and AMable.
  • The new COVID-19 funding round by HORIZONis expected to be launched mid-May.

The full overview of current funding opportunities and relevant (partnering)links are provided here.

Update: COVID-19 R&D Funding April 23rd 2020

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 4/23/2020

Since this Monday’s update, new events and funding have become available!

  • The EU-wide COVID-19 Data Platform is open.
  • Sign up for the Health~Holland COVID-19 virtual partnering event on May 4th.
  • New funding opportunities are open from SNN, EIT Digital and IsDB.
  • The program text with the scope and timing of the ‘Second Wave’ of Dutch government funding for COVID-19 has become available.

The full overview, details and relevant links are provided here.

PREVIOUS PUBLICATIONS

Update: 4/20/2020 – Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants – Link

Update: 4/16/2020 – Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants – Link

Update 4/8/2020 – Specific COVID-19 related funding opportunities for EU-wide and/or Dutch – Link

Life Sciences experts

Our consultants have subject-matter expertise (Postdoc, PhD, MD, MSc) in Life Sciences fields.

Tailored advice

Our consultancy services span the entire Life Sciences value chain, and are always tailored to your specific needs.

Experienced business managers

We have experienced the challenges of managing Life Sciences companies through all different stages, from start-up to controlled growth and successful exit.

Active support

We aim to be a true partner for advice, taking an active, hands-on approach to service provision.

Innovation specialists

For our consultancy, we draw on our continuous academic work on Life Sciences innovation, providing you with evidence-based advice.

International network

We operate at the heart of a vast network of Life Sciences organizations, allowing us to connect and create synergistic partnerships.

Being candid about the risks and opportunities

Being candid about the risks and opportunities that lie ahead of you, we operate from our first-hand experience and expertise to help you and your innovations to become successful. Together we will maximize your chances of success by tailoring our support to your specific needs. This enables you to effectively manage your innovation throughout the complete value chain from the early start, through controlled growth, until a successful exit.